Healthcare provider profile · identity verified

Christopher Michael Dick, APN-C

Nurse Practitioner · WEST DEPTFORD, NJ · NPI 1700176864

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	337	107
Oxycodone Hcl	Oxycodone Hcl	276	31
Alprazolam	Alprazolam	226	41
Gabapentin	Gabapentin	217	54
Lisinopril	Lisinopril	199	57
Amlodipine Besylate	Amlodipine Besylate	191	62
Albuterol Sulfate Hfa	Albuterol Sulfate	187	57
Omeprazole	Omeprazole	157	46
Metformin Hcl Er	Metformin Hcl	156	59
Metoprolol Succinate	Metoprolol Succinate	150	41
Levothyroxine Sodium	Levothyroxine Sodium	148	45
Rosuvastatin Calcium	Rosuvastatin Calcium	135	51
Pantoprazole Sodium	Pantoprazole Sodium	128	40
Fluticasone Propionate	Fluticasone Propionate	119	51
Ozempic	Semaglutide	118	26
Furosemide	Furosemide	116	38
Clonazepam	Clonazepam	114	19
Famotidine	Famotidine	106	27
Losartan Potassium	Losartan Potassium	105	32
Duloxetine Hcl	Duloxetine Hcl	104	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	96	15
Diazepam	Diazepam	95	16
Hydrochlorothiazide	Hydrochlorothiazide	90	31
Tizanidine Hcl	Tizanidine Hcl	89	24
Tamsulosin Hcl	Tamsulosin Hcl	83	24
Quetiapine Fumarate	Quetiapine Fumarate	82	15
Simvastatin	Simvastatin	77	26
Tramadol Hcl	Tramadol Hcl	77	21
Prednisone	Prednisone	73	47
Ibuprofen	Ibuprofen	72	20
Montelukast Sodium	Montelukast Sodium	70	29
Olmesartan Medoxomil	Olmesartan Medoxomil	70	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	13
Eliquis	Apixaban	69	17
Trazodone Hcl	Trazodone Hcl	69	22
Escitalopram Oxalate	Escitalopram Oxalate	67	20
Metformin Hcl	Metformin Hcl	67	24
Triamcinolone Acetonide	Triamcinolone Acetonide	66	15
Oxycontin	Oxycodone Hcl	65	suppressed
Celecoxib	Celecoxib	63	18
Bupropion Xl	Bupropion Hcl	61	13
Metoprolol Tartrate	Metoprolol Tartrate	61	20
Jardiance	Empagliflozin	59	16
Pravastatin Sodium	Pravastatin Sodium	58	18
Ondansetron Hcl	Ondansetron Hcl	57	20
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	55	suppressed
Allopurinol	Allopurinol	54	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	17
Mounjaro	Tirzepatide	52	suppressed
Baclofen	Baclofen	48	16
Carvedilol	Carvedilol	47	14
Sertraline Hcl	Sertraline Hcl	47	15
Zolpidem Tartrate	Zolpidem Tartrate	47	16
Amitriptyline Hcl	Amitriptyline Hcl	45	18
Azelastine Hcl	Azelastine Hcl	45	16
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	45	suppressed
Pregabalin	Pregabalin	45	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Carisoprodol	Carisoprodol	42	suppressed
Lorazepam	Lorazepam	41	12
Ondansetron Odt	Ondansetron	41	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	39	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	39	suppressed
Potassium Chloride	Potassium Chloride	38	12
Clopidogrel	Clopidogrel Bisulfate	37	13
Xarelto	Rivaroxaban	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Glimepiride	Glimepiride	34	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	34	14
Hydroxyzine Hcl	Hydroxyzine Hcl	33	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	11
Finasteride	Finasteride	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Meloxicam	Meloxicam	28	11
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Atenolol	Atenolol	25	suppressed
Lactulose	Lactulose	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Topiramate	Topiramate	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Fluconazole	Fluconazole	24	suppressed
Mupirocin	Mupirocin	24	12
Naproxen	Naproxen	24	suppressed
Xtampza Er	Oxycodone Myristate	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Methylprednisolone	Methylprednisolone	23	19
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Temazepam	Temazepam	23	suppressed
Wegovy	Semaglutide	23	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Valsartan	Valsartan	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Vraylar	Cariprazine Hcl	20	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	19	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Ammonium Lactate	Ammonium Lactate	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Torsemide	Torsemide	17	suppressed
Victoza 3-Pak	Liraglutide	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	15
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Testosterone	Testosterone	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Nurtec Odt	Rimegepant Sulfate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Belbuca	Buprenorphine Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Anastrozole	Anastrozole	12	suppressed
Cephalexin	Cephalexin	12	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error